Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Correlation of IL-17 with immune suppression involving MDSC, malnutrition, and prognosis in patients with gastric and colorectal cancer.
Authors
Kenji Gonda
Fukushima Medical University, Fukushima, Japan
Kenji Gonda, Masahiko Shibata, Daisuke Ujiie, Mai Ashizawa, Tomohiro Kikuchi, Hirokazu Okayama, Shoutarou Fujita, Wataru Sakamoto, Takahiro Nakajima, Hisahito Endo, Motonobu Saito, Tomoyuki Monma, Zenichiro Saze, Shinji Ohki, Koji Kono, Seiichi Takenoshita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 83)
DOI
10.1200/JCO.2018.36.5_suppl.83
Abstract #
83
Poster Bd #
E1
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Correlation of VEGF with immune suppression involving MDSC, malnutrition, and prognosis in patients with gastric and colorectal cancer.
First Author: Kenji Gonda
Poster
2014 Gastrointestinal Cancers Symposium
Serum levels of vascular endothelial growth factor in patients with gastrointestinal cancers and correlation with malnutrition, immunosuppression involving MDSC, and systemic inflammation.
First Author: Kenji Gonda
Poster
2013 Gastrointestinal Cancers Symposium
Correlation of production of IL-17 with immune suppression relating myeloid-derived suppressor cells (MDSC) and nutritional damages in patients with digestive system cancer.
First Author: Kenji Gonda
Poster
2020 Gastrointestinal Cancers Symposium
Association of sarcopenia and myosteatosis with the systemic inflammatory response and tumor stage in patients undergoing surgery for colorectal cancer (CRC).
First Author: Tanvir Abbass